SCHEMBL4706895

SCHEMBL4706895

Cc1ccc(NC(=O)c2nnn(Cc3cc(C(F)(F)F)cc(C(F)(F)F)c3)c2-c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.53
PTGDR2 Q9Y5Y4 3/20 0.51
KDM4E B2RXH2 3/20 0.49
TP53 P04637 2/20 0.49
ALDH1A1 P00352 4/20 0.49
CYP19A1 P11511 2/20 0.49
HSD17B10 Q99714 1/20 0.48
MAPT P10636 3/20 0.47
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.46
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
NR3C1 P04150 1/20 0.45
GAA P10253 1/20 0.45
P2RY14 Q15391 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4708362 0.93 ALDH1A1 (0.56) SMN1; SMN2PTGDR2TP53ALDH1A1CYP19A1
SCHEMBL4638473 0.82 ALDH1A1 (0.65) SMN1; SMN2ALDH1A1CYP19A1AKR1C3AKR1C2
SCHEMBL4707735 0.82 TACR1 (0.52) TP53ALDH1A1CYP19A1GAA
SCHEMBL4707976 0.82 CYP19A1 (0.57) SMN1; SMN2KDM4EALDH1A1CYP19A1MAPT
SCHEMBL4706776 0.81 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1CYP19A1AKR1C3AKR1C2
SCHEMBL4706714 0.81 TACR1 (0.48) ALDH1A1CYP19A1GAA
SCHEMBL4637752 0.80 CYP19A1 (0.74) SMN1; SMN2TP53ALDH1A1CYP19A1MAPT
SCHEMBL4706967 0.79 POLB (0.50) ALDH1A1GAA
SCHEMBL4707843 0.78 EPHX2 (0.48) ALDH1A1GAA
SCHEMBL4706773 0.78 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1CYP19A1AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501809-B1 TRIAZOLE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2008-01-16 EP disclosed